BERLIN (AP) — Pharmaceutical supplier Lonza of Switzerland says it is buying InterHealth Nutraceuticals, Inc., a California-based company that makes ingredients for use in dietary supplements, in a deal worth up to $300 million.
InterHealth, a portfolio company of Kainos Capital, is based in Benicia, California. Lonza said Monday that the deal is expected to close in September and will have an immediate positive impact on its earnings.
Lonza says InterHealth has a range of over 15 branded ingredients and the acquisition will complement its own sports nutrition, weight-loss and pet health offerings among others.
